XSHG
600078
Market cap986mUSD
Oct 09, Last price
9.98CNY
1D
2.25%
1Q
-8.10%
Jan 2017
39.78%
Name
Jiangsu Chengxing Phosph-Chemicals Co.
Chart & performance
P/E
797.27
P/S
1.88
EPS
0.01
Div yield, %
0.32%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
2.71%
Revenues
3.58b
+6.82%
Net income
8m
P
CFO
377m
+40.40%
Dividend
Jul 10, 20240.031 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiangsu ChengXing Phosph-Chemicals Co., Ltd. is a Chinese enterprise specializing in the production, distribution, and sale of advanced phosphorous chemical products. Operating from its base in Jiangyin, the company's extensive portfolio encompasses a variety of phosphorous chemicals, categorized by their application suitability as dental, food, and industrial (technical) grades. Specific offerings include compounds such as dicalcium phosphate, dipotassium phosphate, disodium dihydrogen pyrophosphate, disodium phosphate dihydrate, monosodium phosphate monohydrate, phosphoric acid, potassium pyrophosphate, sodium hexametaphosphate, sodium pyrophosphate, sodium tripolyphosphate, tricalcium phosphate, and trisodium phosphate. In addition to these, the firm also supplies petrochemicals. Established in 1984, Jiangsu ChengXing Phosph-Chemicals serves clients across China.
Key people
Xing Li
Chairman of the Board · since 2006
Zhongming Zhou
Chief Financial Officer, Director · since 2012
Bendu Fu
Vice Chairman of the Board, General Manager · since 2012
Zhenghua Xia
Secretary of the Board · since 2011
Qixia Li
Director · since 2012
Wenxian Qian
Deputy General Manager, Director · since 2012
Junfeng Zhao
Deputy General Manager, Director · since 2014
Independent Director · since 2012
Independent Director · since 2012
Independent Director · since 2012
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||